284 related articles for article (PubMed ID: 28741720)
1. Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.
Fontaine GV; Smith SM
Pharmacotherapy; 2017 Oct; 37(10):e103-e106. PubMed ID: 28741720
[TBL] [Abstract][Full Text] [Related]
2. Thrombolysis After Protamine Reversal of Heparin for Acute Ischemic Stroke After Cardiac Catheterization: Case Report and Literature Review.
Warner DS; Schwartz BG; Babygirija R; Rovin RA; Kassam AB; Biddick L; Sajjad R; Chohan A; Panichpisal K
Neurologist; 2018 Nov; 23(6):194-196. PubMed ID: 30379743
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review.
Ranasinghe T; Mays T; Quedado J; Adcock A
J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104283. PubMed ID: 31324409
[TBL] [Abstract][Full Text] [Related]
4. The Use of Antiplatelet Agents and Heparin in the 24-Hour Postintravenous Alteplase Window for Neurointervention.
Binning MJ; Maxwell CR; McAree M; Veznedaroglu E; Felbaum DR; Arthur A; Goyal N; Wolfe SQ; Tschoe C; Crowley RW; Levy E; Vakharia K; Rai HH; Pandey AS; Daou BJ; Tawk RG; Ringer AJ; Liebman KM
Neurosurgery; 2021 Mar; 88(4):746-750. PubMed ID: 33442725
[TBL] [Abstract][Full Text] [Related]
5. Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.
Maneno JN; Ness GL
Ann Pharmacother; 2021 Feb; 55(2):261-264. PubMed ID: 32667214
[TBL] [Abstract][Full Text] [Related]
6. Acute ischemic stroke after cardiac catheterization: the protamine low-dose recombinant tissue plasminogen activator pathway.
Guevara C; Quijada A; Rosas C; Bulatova K; Lara H; Nieto E; Morales M
Blood Coagul Fibrinolysis; 2017 Apr; 28(3):261-263. PubMed ID: 27214037
[TBL] [Abstract][Full Text] [Related]
7. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis for Acute Ischemic Stroke After Protamine Reversal of Heparin.
Danoun O; Sachar P; Rajamani K
Am J Ther; 2018; 25(5):e552-e554. PubMed ID: 29199997
[No Abstract] [Full Text] [Related]
9. Heparin reversal in off-pump coronary artery bypass surgery: complete, partial, or no reversal?
Gatti G; Pugliese P
Cardiovasc Surg; 2002 Jun; 10(3):245-50. PubMed ID: 12044433
[TBL] [Abstract][Full Text] [Related]
10. Effects of differing rates of protamine reversal of heparin anticoagulation.
Wakefield TW; Hantler CB; Wrobleski SK; Crider BA; Stanley JC
Surgery; 1996 Feb; 119(2):123-8. PubMed ID: 8571194
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of i.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset.
Otwell JL; Phillippe HM; Dixon KS
Am J Health Syst Pharm; 2010 Jul; 67(13):1070-4. PubMed ID: 20554592
[TBL] [Abstract][Full Text] [Related]
12. Readministration of intravenous alteplase in acute ischemic stroke patients: case series and systematic review.
Qureshi AI; Malik AA; Freese M; Thompson MJ; Khan AA; Suri MF
Am J Emerg Med; 2015 Feb; 33(2):307.e1-4. PubMed ID: 25190550
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
Calvet D; Bracard S; Mas JL;
Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
[TBL] [Abstract][Full Text] [Related]
14. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
Parsons MW; Miteff F; Bateman GA; Spratt N; Loiselle A; Attia J; Levi CR
Neurology; 2009 Mar; 72(10):915-21. PubMed ID: 19273826
[TBL] [Abstract][Full Text] [Related]
15. Safe use of alteplase in a 10 months old infant with cardio-embolic stroke.
Rener-Primec Z; Švigelj V; Vesel S; Lovrič D; Škofljanec A
Eur J Paediatr Neurol; 2013 Sep; 17(5):522-5. PubMed ID: 23603009
[TBL] [Abstract][Full Text] [Related]
16. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
[TBL] [Abstract][Full Text] [Related]
17. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
[TBL] [Abstract][Full Text] [Related]
18. Is heparin reversal required for the safe performance of percutaneous endovascular aortic aneurysm repair?
Jabori S; Jimenez JC; Gabriel V; Quinones-Baldrich WJ; Derubertis BG; Farley S; Gelabert HA; Rigberg DA
Ann Vasc Surg; 2013 Nov; 27(8):1049-53. PubMed ID: 24011808
[TBL] [Abstract][Full Text] [Related]
19. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
Patel AA; White CM; Coleman CI
Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
[No Abstract] [Full Text] [Related]
20. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
